元宇宙概念股雲想科技(2131.HK)飆升漲33%
格隆匯12月30日丨在A股市場元宇宙概念股活躍,商湯(0020.HK)首日上市大漲之際,港股元宇宙概念股雲想科技(2131.HK)今日盤中亦隨之飆升,一度漲33%報2.7港元。商湯集團是雲想科技的基石投資者。目前,雲想科技與商湯集團正進行人工智能技術的工程化研發合作,預期在元宇宙概念興起及市場對優質視頻需求日益增加的趨勢下,相關技術將大幅提升視頻製作能力及效率,協助公司捕捉更多商機。雲想科技首席財務官林芊表示,公司與商湯集團的商業及技術合作已成功協助提升公司客户的營銷效率及公司競爭力,人工智能技術在短視頻製作領域的發展趨勢中將不可或缺,憧憬未來進一步加深與商湯的研發及商業合作,共同為客户帶來更好的技術與服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.